GB201010682D0 - Methods for treatment and prevention of infection - Google Patents
Methods for treatment and prevention of infectionInfo
- Publication number
- GB201010682D0 GB201010682D0 GBGB1010682.1A GB201010682A GB201010682D0 GB 201010682 D0 GB201010682 D0 GB 201010682D0 GB 201010682 A GB201010682 A GB 201010682A GB 201010682 D0 GB201010682 D0 GB 201010682D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- infection
- prevention
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Ecology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51025705A | 2005-05-19 | 2005-05-19 | |
US68929905P | 2005-06-10 | 2005-06-10 | |
GB0723902A GB2441094B (en) | 2005-05-19 | 2006-05-19 | Methods for treatment and prevention of infection |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201010682D0 true GB201010682D0 (en) | 2010-08-11 |
GB2468803A GB2468803A (en) | 2010-09-22 |
GB2468803B GB2468803B (en) | 2011-01-19 |
Family
ID=42582962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1010682A Expired - Fee Related GB2468803B (en) | 2005-05-19 | 2006-05-19 | Screening methods for bacterial killing |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2468803B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005286798A1 (en) * | 2004-09-21 | 2006-03-30 | Sanofi Pasteur, Inc. | Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
EP2213298A3 (en) * | 2004-10-21 | 2011-07-20 | Wyeth LLC | Immunogenic compositions of staphylococcus epidermidis polypeptide and polynucleotide antigens |
-
2006
- 2006-05-19 GB GB1010682A patent/GB2468803B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB2468803B (en) | 2011-01-19 |
GB2468803A (en) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200709727B (en) | Compounds and methods for the treatment of prevention of flavivirus infections | |
HK1146084A1 (en) | Methods and compositions for prevention or treatment of rsv infection | |
HK1108168A1 (en) | Vaccine for prevention and treatment of hiv-infection | |
IL178996A0 (en) | Thienopyridinone compounds and methods of treatment | |
EP1991270A4 (en) | Compositions and methods for prevention and treatment of cachexia | |
EP2007284A4 (en) | Devices and methods for treatment of tissue | |
IL194820A0 (en) | Devices and methods for treatment of tissue | |
ZA200704909B (en) | Method of treatment or prophylaxis | |
HK1134679A1 (en) | Compositions and methods for the treatment of infections | |
IL190478A0 (en) | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection | |
IL182436A0 (en) | Thienopyridinone compounds and methods of treatment | |
GB0610350D0 (en) | prevention and/or treatment of neuodegenerative disorders | |
AP2009004840A0 (en) | Compounds and methods for treatment of HCV | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
EP1753777A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a | |
IL187405A0 (en) | Methods and compositions for the treatment of pain | |
ZA200709024B (en) | Method of well treatment and construction | |
GB2441094B (en) | Methods for treatment and prevention of infection | |
GB0426196D0 (en) | Methods of treatment | |
SI1812797T1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
GB0504657D0 (en) | Compositions and methods of treatment | |
GB201010682D0 (en) | Methods for treatment and prevention of infection | |
GB0510257D0 (en) | Methods for treatment and prevention of infection | |
ZA200710476B (en) | Methods and compositions for the treatment of pain | |
ZA200902434B (en) | Compounds and methods for treatment of HCV |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20150519 |